![Rosemary Williams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rosemary Williams
Keine laufenden Positionen mehr
Profil
Rosemary Williams worked as the Chief Accounting Officer, VP-Finance & Controller at Bellicum Pharmaceuticals, Inc. from 2018 to 2020.
She obtained an undergraduate degree from the University of Utah in 1985.
Ehemalige bekannte Positionen von Rosemary Williams
Unternehmen | Position | Ende |
---|---|---|
BELLICUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 08.01.2020 |
Ausbildung von Rosemary Williams
University of Utah | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Bellicum Pharmaceuticals, Inc.
![]() Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |